Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease
- PMID: 10201412
- PMCID: PMC1736304
- DOI: 10.1136/jnnp.66.4.431
Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease
Abstract
Objectives: To identify the clinical and demographic factors that are associated with a poor quality of life in patients with Parkinson's disease.
Methods: 233 of a total of 245 patients identified in a community based study in a Norwegian county participated in the study. Quality of life was measured by the Nottingham Health Profile (NHP). The results were compared with those in 100 healthy elderly people. Clinical and demographic variables were determined during a semistructured interview and by clinical examination by a neurologist. Multiple regression analyses were used to determine which variables were associated with higher distress scores.
Results: Patients with Parkinson's disease had higher distress scores than the healthy elderly people for all the NHP dimensions. The variables that most strongly predicted a high total NHP score were depressive symptoms, self reported insomnia, and a low degree of independence, measured by the Schwab and England scale. Severity of parkinsonism contributed, but to a lesser extent. Nearly half the patients with Parkinson's disease reported lack of energy, compared with a fifth of the control group. Severity of depressive symptoms and a higher score on the UPDRS motor subscale only partly accounted for this finding. Only 30% of the variation in NHP energy score was explained by the predictive variables identified in this study.
Conclusions: Parkinson's disease has a substantial impact on health related quality of life. Depressive symptoms and sleep disorders correlated strongly with high distress scores. Patients with Parkinson's disease should be examined for both conditions, which require treatment. Low energy was commonly reported and may be a separate entity of Parkinson's disease.
Comment in
-
Health outcome measures.J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):416. doi: 10.1136/jnnp.66.4.416. J Neurol Neurosurg Psychiatry. 1999. PMID: 10201410 Free PMC article. No abstract available.
Similar articles
-
Health related quality of life in Parkinson's disease: a prospective longitudinal study.J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):584-9. doi: 10.1136/jnnp.69.5.584. J Neurol Neurosurg Psychiatry. 2000. PMID: 11032608 Free PMC article.
-
Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms.Health Qual Life Outcomes. 2015 Jun 20;13:83. doi: 10.1186/s12955-015-0281-x. Health Qual Life Outcomes. 2015. PMID: 26088201 Free PMC article.
-
Fatigue in patients with Parkinson's disease.Mov Disord. 1999 Mar;14(2):237-41. doi: 10.1002/1531-8257(199903)14:2<237::aid-mds1006>3.0.co;2-x. Mov Disord. 1999. PMID: 10091615
-
Gender Differences and Quality of Life in Parkinson's Disease.Int J Environ Res Public Health. 2020 Dec 29;18(1):198. doi: 10.3390/ijerph18010198. Int J Environ Res Public Health. 2020. PMID: 33383855 Free PMC article. Review.
-
The impact of mood disorders in neurological diseases: should neurologists be concerned?Epilepsy Behav. 2003 Oct;4 Suppl 3:S3-13. doi: 10.1016/j.yebeh.2003.08.018. Epilepsy Behav. 2003. PMID: 14592635 Review.
Cited by
-
Frontal Transcranial Direct Current Stimulation as a Potential Treatment of Parkinson's Disease-Related Fatigue.Brain Sci. 2021 Apr 8;11(4):467. doi: 10.3390/brainsci11040467. Brain Sci. 2021. PMID: 33917684 Free PMC article. Review.
-
Psychiatric aspects of Parkinson's disease.J Neurosci Rural Pract. 2015 Jan;6(1):65-76. doi: 10.4103/0976-3147.143197. J Neurosci Rural Pract. 2015. PMID: 25552854 Free PMC article. Review.
-
Quality of life in Parkinson's disease.J Med Life. 2012 Dec 15;5(4):375-81. Epub 2012 Dec 25. J Med Life. 2012. PMID: 23346238 Free PMC article. Review.
-
Multi-night cortico-basal recordings reveal mechanisms of NREM slow wave suppression and spontaneous awakenings at high-temporal resolution in Parkinson's disease.Res Sq [Preprint]. 2023 Nov 7:rs.3.rs-3484527. doi: 10.21203/rs.3.rs-3484527/v1. Res Sq. 2023. Update in: Nat Commun. 2024 Feb 27;15(1):1793. doi: 10.1038/s41467-024-46002-7. PMID: 37986864 Free PMC article. Updated. Preprint.
-
Modafinil for Parkinson's disease fatigue.J Neurol. 2010 Mar;257(3):452-6. doi: 10.1007/s00415-009-5351-8. Epub 2009 Oct 20. J Neurol. 2010. PMID: 19842011 Clinical Trial.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical